Journal
Immunotherapy
Publication Date
10-1-2025
Volume
17
Issue
15
First Page
1115
Last Page
1127
Document Type
Open Access Publication
DOI
10.1080/1750743X.2025.2582464
Rights and Permissions
Cochran HC, Ghobadi KA, Ghobadi A. Chimeric antigen receptor natural killer (CAR-NK) cells: from preclinical promise to clinical reality in cancer immunotherapy. Immunotherapy. 2025 Oct;17(15):1115-1127. doi: 10.1080/1750743X.2025.2582464. © 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
Recommended Citation
Cochran, Hunter Cassidy; Ghobadi, Kevin Ashkan; and Ghobadi, Armin, "Chimeric antigen receptor natural killer (CAR-NK) cells: From preclinical promise to clinical reality in cancer immunotherapy." Immunotherapy. 17, 15. 1115 - 1127. (2025).
https://digitalcommons.wustl.edu/oa_4/6462
Department
ICTS (Institute of Clinical and Translational Sciences)
